Porosome Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $3.63M

  • Investors
  • 1

Porosome Therapeutics General Information

Description

Developer of a drug development platform designed to address diseases caused by secretory defects, including Alzheimer's, cystic fibrosis, and diabetes. The company's platform identifies small molecules for treating diseases and specializes in the development and delivery of next-generation antiviral therapeutics, enabling healthcare professionals to access affordable drugs and treatments.

Contact Information

Formerly Known As
Viron Therapeutics Holdings
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • One Boston Place
  • Suite 2603
  • Boston, MA 02108
  • United States
+1 (617)
Primary Industry
Biotechnology
Other Industries
Enterprise Systems (Healthcare)
Vertical(s)
Corporate Office
  • One Boston Place
  • Suite 2603
  • Boston, MA 02108
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Porosome Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 20-Mar-2026 $3.63M Completed Generating Revenue
1. Seed Round 23-Jun-2022 Completed Generating Revenue
To view Porosome Therapeutics’s complete valuation and funding history, request access »

Porosome Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Pref
To view Porosome Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Porosome Therapeutics Patents

Porosome Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250339383-A1 Functional porosome manipulation Pending 10-Jul-2024
WO-2026015731-A1 Functional porosome manipulation Pending 10-Jul-2024
US-20240053354-A1 Functional porosome manipulation Pending 08-Aug-2022
US-20240316152-A1 Functional porosome manipulation Pending 08-Aug-2022
US-12226431-B2 Aerosol and topical administration of a formulation containing cyclodextrin, quercetin and zinc, in combination or separately, to mitigate infection by enveloped viruses Active 11-Sep-2021 A61K31/724
To view Porosome Therapeutics’s complete patent history, request access »

Porosome Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Porosome Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Private Ventures Group Venture Capital Minority
To view Porosome Therapeutics’s complete investors history, request access »

Porosome Therapeutics FAQs

  • When was Porosome Therapeutics founded?

    Porosome Therapeutics was founded in 2021.

  • Where is Porosome Therapeutics headquartered?

    Porosome Therapeutics is headquartered in Boston, MA.

  • What is the size of Porosome Therapeutics?

    Porosome Therapeutics has 2 total employees.

  • What industry is Porosome Therapeutics in?

    Porosome Therapeutics’s primary industry is Biotechnology.

  • Is Porosome Therapeutics a private or public company?

    Porosome Therapeutics is a Private company.

  • What is Porosome Therapeutics’s current revenue?

    The current revenue for Porosome Therapeutics is .

  • How much funding has Porosome Therapeutics raised over time?

    Porosome Therapeutics has raised $3.93M.

  • Who are Porosome Therapeutics’s investors?

    Private Ventures Group has invested in Porosome Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process